Fortis Healthcare
chain of hospitals in India

Fortis Healthcare Limited is an Indian for-profit private hospital network headquartered in Gurgaon.
The Fortis Memorial Research Institute (FMRI) in Gurgaon serves as the headquarters for Fortis Healthcare. In addition to its Gurgaon facility, Fortis Healthcare operates hospitals in the Delhi NCR, including locations in Faridabad, Noida, Vasant Kunj, and Shalimar Bagh, along with other facilities across India, Dubai, and Sri Lanka. The company currently manages 36 healthcare facilities.
History
Fortis Healthcare was founded in 1996 as an offshoot of the pharmaceutical company Ranbaxy Laboratories. It began operating in Mohali, Punjab, where its first hospital was established. It later expanded by acquiring the healthcare division of Escorts Group, including the Escorts Heart and Research Center, Okhla, Delhi.
In February 2018, founders Malvinder Singh and Shivinder Singh resigned from the board of Fortis Healthcare following allegations that they had siphoned $78 million out of the company. A month earlier, the Delhi High Court had upheld a 2016 Singapore arbitration tribunal order against the Singh brothers to pay ₹3,500 crore ($550 million) in damages to Daiichi Sankyo for misrepresenting information during the sale of Ranbaxy Laboratories.
In March 2018, Manipal Hospitals and TPG Capital offered to buy out Singh brothers' stake in Fortis Healthcare for ₹3,900 crore.
Begin with the source’s own compact description: “Fortis Healthcare” is chain of hospitals in India. The dossier treats that line as a proposition to test through Fortis, Healthcare and chain, not as a finished interpretation.
Why this record matters
The phrase “chain of hospitals in India” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Jun 15, 2026. The linked authority identifier is Q7810035. 2 of 2 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 1996, 2018 and 2016.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Fortis Healthcare”, its source revision and the description used here.
- Expand the search: follow Fortis Healthcare primary sources, Fortis Healthcare archive and Fortis research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Fortis Healthcare”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Fortis Healthcare” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.